Open this publication in new window or tab >>Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China.;Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Hebei North Univ, Affiliated Hosp 1, Dept Resp Med, Zhangjiakou, Peoples R China..
Uppsala University, Disciplinary Domain of Science and Technology, Biology, Department of Cell and Molecular Biology.
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China.;Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China..
Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.;CAMS Collect Ctr Pathogen CAMS Collect Ctr Pathoge, Div Med Microorganisms Related Strains, Beijing, Peoples R China..
Show others...
2025 (English)In: Microbiology Spectrum, E-ISSN 2165-0497, Vol. 13, no 1Article in journal (Refereed) Published
Abstract [en]
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global threat, but the mechanism of non-carbapenemase carbapenem resistance is still unclear. In the current study, we investigated the contributions of point mutations in mexR, oprD, and ftsI to carbapenem resistance in P. aeruginosa during in vivo evolution studies with consecutive clinical isolates. Real-time qPCR and Electrophoretic Mobility Shift Assay demonstrated that MexR (Gln55Pro) mutation increased MexAB efflux pump genes expression by altering MexR's binding capacity, leading to a four- to eight-fold increase in meropenem MIC in the Pae d1 Green triangle mexR and PAO1 triangle mexR mutants. The OprD (Trp415*) truncation affected porin structure, and the constructed mutant Pae d1 Green oprD Trp415* increased meropenem MIC by 16-fold (from 0.25 to 4 mu g/ mL). The contribution of ftsI mutation to meropenem resistance was confirmed by clinical linkage analysis and was estimated to cause a two-fold increase in merope nem MIC by comparing the resistant clinical isolate with the Pae d1 Green oprD Trp415*triangle mexR double mutant. The study found that the oprD Trp415* allele alone accounts for the imipenem MIC in clinical isolates, while the triangle mexR and ftsI Arg504Cys alleles do not contribute to imipenem resistance. In conclusion, we identified and explored the contributions of mexR, oprD, and ftsI mutations to high level non-carbape nemase carbapenem resistance in P. aeruginosa. These findings highlight the interplay of different mutations in causing non-carbapenemase carbapenem-resistance in P. aeruginosa.
Place, publisher, year, edition, pages
American Society for Microbiology, 2025
Keywords
Pseudomonas aeruginosa, carbapenem resistance, in vivo evolution, overlaying point mutation
National Category
Microbiology in the Medical Area Microbiology
Identifiers
urn:nbn:se:uu:diva-555185 (URN)10.1128/spectrum.01398-24 (DOI)001357953600001 ()39555917 (PubMedID)
2025-04-232025-04-232025-04-23Bibliographically approved